Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | DAREDare Bioscience, Inc.FY2025 · Dec |
|---|---|
| Revenue | $1.03M |
| Revenue, yoy | +10,429.4% |
| Net income | $13.40M |
| Net income, yoy | −230.6% |
| Net margin | -1,300.7% |
| Free cash flow | $10.27M |
| FCF margin | -997.0% |
| EPS, diluted | $1.20 |
Add another company.